Issue |
E3S Web Conf.
Volume 619, 2025
3rd International Conference on Sustainable Green Energy Technologies (ICSGET 2025)
|
|
---|---|---|
Article Number | 04001 | |
Number of page(s) | 10 | |
Section | Materials for a Sustainable Future | |
DOI | https://doi.org/10.1051/e3sconf/202561904001 | |
Published online | 12 March 2025 |
“Nanoparticles as Vaccine Heroes: Unveiling Their Impact” – A Review
1 Assistant Professor, School of Pharmacy, RK University, Rajkot.
2 Professor, Vardhaman College of Engineering, Hyderabad, India
* Corresponding author: ishita.zalavadiya@rku.ac.in
Nanoparticles are essential for the advancement of vaccine administration and development because they help create immunisation plans that are more focused, safe, and effective. This abstract delves into the various functions of nanoparticles in vaccines, highlighting how they can boost immunogenicity, stabilise antigens, and enable regulated release. Tailored techniques to treat infectious diseases are made possible by the diverse carriers that nanoparticles, such as liposomes, polymeric nanoparticles, and virus-like particles, provide for antigens, adjuvants, or nucleic acids. These nanoscale platforms enable the co-delivery of several components to elicit strong and durable immune responses in addition to optimising antigen presentation to the immune system. Additionally, their capacity for immune system modification and mucosal administration creates new opportunities for the creation of vaccines against a variety of diseases. By addressing issues including antigen degradation, low immunogenicity, and the requirement for adjuvants, the use of nanotechnology into vaccine design presents a viable avenue to overcoming the present barriers to vaccination efficacy. The use of nanoparticles into vaccines highlights their revolutionary potential to revolutionise preventative medicine and provide novel approaches to address worldwide health issues.
Key words: Nanoparticles / Vaccines / Nanotechnology / Nanovaccinology / Adjuvant
© The Authors, published by EDP Sciences, 2025
This is an Open Access article distributed under the terms of the Creative Commons Attribution License 4.0, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
Current usage metrics show cumulative count of Article Views (full-text article views including HTML views, PDF and ePub downloads, according to the available data) and Abstracts Views on Vision4Press platform.
Data correspond to usage on the plateform after 2015. The current usage metrics is available 48-96 hours after online publication and is updated daily on week days.
Initial download of the metrics may take a while.